He describes a 67-year-old man with recurrent T1 disease after BCG who refused cystectomy despite high-risk features including lymphovascular invasion. Dr. Tyson outlines multiple treatment options ...

Patients with high-risk, non-metastatic prostate cancer (HR PCa) are often eligible for both (robot-assisted) radical prostatectomy (RP) and external beam radiation therapy (EBRT), the latter ...

The relationship between perioperative physical activity, fitness, and postoperative outcomes has long been a subject of debate. Studies in orthopedics and general surgery have provided some evidence ...

Emerging imaging-guided technologies, such as prostate-specific membrane antigen radioguided surgery (PSMA-RGS) and augmented reality (AR), could enhance the precision and efficacy of robot-assisted ...

Telehealth and direct-to-consumer healthcare platforms have reshaped the way patients interact with healthcare systems, especially regarding sensitive conditions such as erectile dysfunction (ED) and ...

For patients with muscle-invasive bladder cancer (MIBC), time to cystectomy and receipt of neoadjuvant chemotherapy are associated with improved survival. Travel burden may be an important barrier to ...

Our recent study unveils the intricate role of N⁶-methyladenosine (m6A) in shaping prostate cancer heterogeneity. 1 By mapping the m6A landscape across 162 localized primary prostate tumors, we ...

The potential influence of radical prostatectomy on tumor cell release into the blood circulation is an under-investigated area. One hundred three treatment-naïve patients with early-stage prostate ...

Radical nephroureterectomy (RNU) is the standard treatment for upper tract urothelial carcinoma (UTUC). Minimally invasive techniques like robotic (RARNU) and laparoscopic (LRNU) RNU offer potential ...

The study identifies and summarizes information from manuscripts using simulation models for Bladder Cancer (BCA) research. We conducted and presented results of a systematic literature search of ...

With multiple oral medications currently available for patients with prostate cancer, there is a need to understand how patients' preferences and experiences are impacted by several factors including ...

Background: Squamous cell carcinoma (SCC) of the penis accounts for approximately 95% of penile cancers and is associated with substantial morbidity and mortality. SCC typically develops in ...